Ginsenoside Rb1, a principal effective ingredient of Panax notoginseng, produces pain antihypersensitivity by spinal microglial dynorphin A expression
- 8 November 2022
- journal article
- research article
- Published by Elsevier in Neuroscience Research
- Vol. 188, 75-87
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- The role of spinal adrenergic receptors on the antinociception of ginsenosides in a rat postoperative pain modelKorean Journal of Anesthesiology, 2013
- Anti-Inflammatory Mechanism of Compound K in Activated Microglia and Its Neuroprotective Effect on Experimental Stroke in MiceThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Therapeutic effect of Yunnan Baiyao on rheumatoid arthritis was partially due to regulating arachidonic acid metabolism in osteoblastsJournal of Pharmaceutical and Biomedical Analysis, 2012
- Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginsengJournal of Ginseng Research, 2012
- Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cellsBritish Journal of Pharmacology, 2009
- CB2receptors in the brain: role in central immune functionBritish Journal of Pharmacology, 2008
- The neuropathic pain triad: neurons, immune cells and gliaNature Neuroscience, 2007
- Ginsenoside Rb1 inhibits tube‐like structure formation of endothelial cells by regulating pigment epithelium‐derived factor through the oestrogen β receptorBritish Journal of Pharmacology, 2007
- Comparative Study on Triterpene Saponins of Ginseng DrugsPlanta Medica, 2004
- Antinociceptive Effects of Ginsenosides Injected Intracerebroventricularly or Intrathecally in Substance P-Induced Pain ModelPlanta Medica, 2003